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A characteristic of endothelial dysfunction, which is observed in the beginning stages of type 2 diabetes, is
the alteration of the microvascular barrier, affecting the microvascular permeability.  We measured the
venular leakage and clearance of albumin in response to suffusion with high-dose insulin (10e-7M) in the
autoperfused mesentery in the adult male (AM), adult female (AF), and juvenile male (JM) rats.  Insulin
suffusion lead to increased venular albumin leakage by 63% in AM rats.  Albumin and total protein
clearance decreased with insulin treatment and hence, had an inverse relationship.  In the JM rats, venular
albumin leakage increased by 103% with insulin suffusion.  The total protein clearance in JM was
unchanged, while the albumin clearance increased with insulin suffusion, resulting in an uncoupling of the
responses.  In the AM rats, venular albumin leakage was unchanged with insulin suffusion.  Insulin also
decreased the total protein clearance, but not the albumin clearance.  We demonstrated that not only can
insulin result in changes in macromolecule exchange in intact, mesenteric microvasculature, but that these
changes were dependent on the sex and the sexual maturity of the animal.  We determined that the venular
leakage response at the single vessel does not reflect the overall protein clearance of the mesenteric
network.  The uncoupling of the relationship between albumin and total protein clearance response with
insulin provides evidence that albumin movement from the vessel and through the tissue is regulated via
different mechanisms compared to other plasma proteins.  The implication from our studies suggest that the
treatment and progression of diseases need to be considered with the genomic and phenotypic
backgrounds in mind.
